Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular
Pharma
Esperion pays $75M for Corstasis and FDA-approved nasal spray
Esperion has paid $75 million upfront to acquire Corstasis Therapeutics and its nasal spray Enbumyst, which was approved by the FDA six months ago.
Kevin Dunleavy
Mar 3, 2026 8:40am
Stada sets sights on €85M Saudi Arabia manufacturing hub
Feb 17, 2026 2:28pm
Novo snags FDA nod for oral obesity med with Wegovy in a pill
Dec 22, 2025 6:59pm
Amgen's Repatha meets the mark in CV primary prevention trial
Oct 2, 2025 11:26am
Novartis to lay off 427 staffers amid marketing model rework
Mar 18, 2025 10:19am
A heartwarming review of cardiovascular news, most-loved stories
Feb 14, 2025 9:00am
